William Atkins
By

William Atkins joined FLG in 2023 with over 30 years of experience as both CFO of and advisor to public and private technology companies. He has led the finance function at both large companies ($1B+ revenues) and high growth VC and PE backed companies (A through D Rounds) with heavy…Read More

Read More
Mark S. Blumenkranz, CEO & Chairman
By

“I’ve had the fortunate opportunity  to work closely with Mark Murray of FLG Partners in a series of  four  successful venture backed -backed companies in Silicon Valley  over the past dozen years including Optimedica Corporation (acquired by Abbott), Oculeve (acquired by Allergan), Oyster Point Pharmaceuticals (IPO) and most recently Kedalion Therapeutics (acquired by Novartis)….Read More

Read More
Angion Biomedica Corp.
By
Read More
Human API
By
Read More